Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

890.408
-22.370-2.45%
Number of Gainers:1
Number of Losers:16
Number of Flat:- -
PE:- -
High:911.751
Open:911.751
Low:887.660
Close:912.778
Volume:390.86M
Turnover:2.96B
Market Cap:600.58B
Float Cap:498.11B

Loading ...

Sino Biopharmaceutical Stock Slides 2.3% in Hong Kong

Dow Jones
·
2 hours ago

CSPC Pharmaceutical Group Stock Slips 3.6% in Hong Kong, Underperforms Competitors

Dow Jones
·
2 hours ago

AH Share Premium Rankings: September 10 Market Close Update

Stock News
·
2 hours ago

Global Equities Roundup: Market Talk

Dow Jones
·
3 hours ago

Hong Kong Market Flash | CSPC Pharma Drops Over 4% as Lp(a) HORIZON Study Setback May Pressure Participants Including the Company

Stock News
·
4 hours ago

CSPC Pharma's Clinical Data Presentations Could be Near-Term Share Catalysts

Dow Jones
·
4 hours ago

Morning Selloff Hits Mobile Supply Chain Stocks as Apple's Launch Fails to Offset Cost Pressures

Stock News
·
7 hours ago

Ascletis Pharma Surges on US Obesity Drug Trial Launch

Deep News
·
9 hours ago

Pharmaceutical Firms Divest Assets to Bolster Core Operations

Deep News
·
Yesterday

Trump Unveils Midterm Strategy: Tax Cuts and "MAHA Movement" Take Center Stage, Targeting Pharma and Processed Food Sectors

Stock News
·
Yesterday

Fosun Pharma's New Oral Drug for Vitiligo Gets Green Light for Phase III Trials

Deep News
·
Yesterday

Genfleet-B Repurchases 75,000 Shares for HK$1.96 Million on September 9

Stock News
·
Yesterday

CSPC Pharma Gets Clinical Trial Nod in China for Solid Tumors Drug

MT Newswires Live
·
Yesterday

CSPC Pharmaceutical Says Rotigotine Long-Acting Injection Gets Clinical Trial Approval in China

Reuters
·
Yesterday

CSPC Pharma's Goserelin Extended-Release Injection Gets Clinical Trial Green Light in China

Stock News
·
Yesterday

CSPC Pharma Gains Chinese Clinical Trial Approval for Goserelin Extended-Release Injection

Stock News
·
Yesterday

CSPC Pharma Wins China Clinical Trial Clearance for Syh9102 Goserelin Injection

Reuters
·
Yesterday

CSPC Pharmaceutical - Goserelin Sustained-Release Injection (Syh9102 Injection) Obtains Clinical Trial Approval in China

THOMSON REUTERS
·
Yesterday

Fosun Pharma Spends HK$2.63 Million Buying Back Shares on September 9

Stock News
·
Yesterday

Alibaba Health Information Technology Stock Slips 2.9% in Hong Kong

Dow Jones
·
Yesterday